跳至主要内容
临床试验/NCT03922542
NCT03922542已完成2 期

Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia

Price Vision Group3 个研究点 分布在 1 个国家目标入组 508 人开始时间: 2019年4月16日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
508
试验地点
3
主要终点
Change in maximum keratometry

研究概览

简要总结

The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
10 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Documented keratoconus or ectasia after refractive surgery

排除标准

  • Insufficient corneal thickness
  • Ocular condition that may predispose the eye to complications
  • History of chemical injury or delayed epithelial healing
  • Condition that would interfere with or prolong epithelial healing
  • Known sensitivity to treatment medications
  • Pregnancy

研究组 & 干预措施

Accelerated

Active Comparator

Treatment with 0.1% riboflavin eye drops and 9 mW/cm2 UVA light for 10 minutes

干预措施: riboflavin 0.1% (Combination Product)

Standard

Active Comparator

Treatment with 0.1% riboflavin eye drops and 3 mW/cm2 UVA light for 30 minutes

干预措施: Riboflavin 0.1% (Combination Product)

结局指标

主要结局

Change in maximum keratometry

时间窗: 6 months

assessed by corneal tomography

次要结局

  • Change in uncorrected distance visual acuity(6 months)
  • Change in corrected distance visual acuity(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验